The first study to identify IGF-1R in ES reported the expression of IGF-1 and IGF-1R in ES tumors and demonstrated in vitro growth inhibition using the anti-IGF-1R antibody αIR3 [2]. The gene discussed is IGF1R; the disease is Ewing sarcoma.